Ace the CITI Training Test 2025 – Rock Your Research Cred!

Question: 1 / 400

21 CFR 312.62 deals with which of the following?

Investigational new drug application (IND)

Bioavailability and bioequivalence

Handling of controlled substances

Investigator recordkeeping and reports

21 CFR 312.62 specifically deals with the requirements for investigator recordkeeping and reports for clinical investigations of drug products. Options A, B, and C are incorrect because

- Option A, Investigational new drug application (IND), is covered under 21 CFR 312.23 and 312.30.

- Option B, Bioavailability and bioequivalence, is covered under 21 CFR 320.

- Option C, Handling of controlled substances, is covered under 21 CFR 1301, not 21 CFR 312.62.

Therefore, the correct answer is D because it is the only option that is directly related to investigator recordkeeping and reports.

Get further explanation with Examzify DeepDiveBeta
Next Question

Report this question

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy